.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Teva
US Army
Healthtrust
Merck
Novartis
Colorcon
Express Scripts
Boehringer Ingelheim

Generated: November 19, 2017

DrugPatentWatch Database Preview

Desvenlafaxine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desvenlafaxine and what is the scope of desvenlafaxine freedom to operate?

Desvenlafaxine
is the generic ingredient in four branded drugs marketed by Alembic Pharms Ltd, Osmotica Pharm Corp, Teva Pharms Usa, Sun Pharma Global, Zydus Pharms Usa Inc, Sandoz Inc, Actavis Labs Fl, Lupin Ltd, West-ward Pharms Int, Wyeth Pharms Inc, and Mylan Pharms Inc, and is included in thirteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for desvenlafaxine. Three suppliers are listed for this compound. There is one tentative approval for this compound.

Tentative approvals for DESVENLAFAXINE

Applicant Application No. Strength Dosage Form
u► Subscribe50MGTABLET, EXTENDED RELEASE;ORAL
u► Subscribe100MGTABLET, EXTENDED RELEASE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204082-001Feb 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204020-002Oct 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Osmotica Pharm Corp
KHEDEZLA
desvenlafaxine
TABLET, EXTENDED RELEASE;ORAL204683-002Jul 10, 2013BCRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204172-001Jun 29, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204172-002Jun 29, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204065-002Jul 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
DESVENLAFAXINE
desvenlafaxine
TABLET, EXTENDED RELEASE;ORAL204150-002Mar 4, 2013BCRXYesYes► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
DESVENLAFAXINE
desvenlafaxine fumarate
TABLET, EXTENDED RELEASE;ORAL205208-002Oct 11, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204003-002Jun 29, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate
TABLET, EXTENDED RELEASE;ORAL204003-001Jun 29, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Baxter
Merck
Novartis
UBS
Queensland Health
Chinese Patent Office
Healthtrust
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot